Does biologic therapy increase serious infection risk?

Full Article


A recent study concluded that psoriasis patients receiving the biologic treatment infliximab (Remicade) are at a higher risk of contracting a serious infection that could lead to hospitalization, and even death, in comparison to patients receiving a non-biologic treatment alternative. Researchers concluded safer methods for treating psoriasis include exposure to topical and ultraviolet light therapies.